India Partially Lifts Malaria Drug Export Ban on Trump Call
- Trump advocates relatively untested drug for Covid-19 care
- India’s recent export ban had cut half of U.S.’s supplies
This article is for subscribers only.
India partially lifted a ban on the exports of a malaria drug after President Donald Trump sought supplies for the U.S., according to government officials with knowledge of the matter.
Exports of hydroxychloroquine and paracetamol will be allowed depending on availability of stock after meeting domestic requirements and existing orders, said the government officials, who asked not to be identified citing rules. Shipments will be restricted and permission will be on humanitarian ground, they added.